(Q35782236)

10 August 2017

Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease (English)

1 reference

gestational trophoblastic disease

10 August 2017

1 reference

A Estellés

1

1 reference

10 August 2017

S Grancha

2

1 reference

10 August 2017

J Gilabert

3

1 reference

10 August 2017

T Thinnes

4

1 reference

10 August 2017

M Chirivella

5

1 reference

10 August 2017

F España

6

1 reference

10 August 2017

J Aznar

7

1 reference

10 August 2017

D J Loskutoff

8

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

The American Journal of Pathology

10 August 2017

1 reference

10 August 2017

149

1 reference

10 August 2017

4

1 reference

10 August 2017

1229-1239

1 reference

Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Regulation of plasminogen activator inhibitor-1 levels in human monocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Recent aspects of hemostasis, hematology and hemorheology in preeclampsia-eclampsia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Plasminogen activator inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Predictive value of increased plasma levels of fibronectin in gestational hypertension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Type 1 plasminogen activator inhibitor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Hepatocyte growth factor in human placenta and trophoblastic disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Isolation of Plasminogen Activator Inhibitor-2 (PAI-2) from Human Placenta. Evidence for Vltronectin/PAI-2 Complexes in Human Placenta Extract

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1865200

Coagulation and fibrinolysis in intact hydatidiform molar pregnancy

12 July 2018

1 reference

12 December 2020

Haemostatic and rheological changes in normal pregnancy and pre-eclampsia

1 reference

12 December 2020

Fibrinolytic activity and protein C in preeclampsia

1 reference

12 December 2020

Cellular localisation in placenta of placental type plasminogen activator inhibitor

1 reference

12 December 2020

The enhanced production of placental interleukin-1 during labor and intrauterine infection

1 reference

12 December 2020

Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia

1 reference

12 December 2020

Fibrinolytic components in fetal membranes and amniotic fluid

1 reference

12 December 2020

Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole

1 reference

12 December 2020

Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts

1 reference

12 December 2020

Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation

1 reference

12 December 2020

Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation

1 reference

12 December 2020

The enigma PAI-2. Gene expression, evolutionary and functional aspects

1 reference

12 December 2020

The fibrinolytic activity of the human endometrium

1 reference

12 December 2020

Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues

1 reference

12 December 2020

Placental-type plasminogen activator inhibitor in preeclampsia

1 reference

12 December 2020

Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)

1 reference

12 December 2020

Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts

1 reference

12 December 2020

Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia

1 reference

12 December 2020

Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia

1 reference

12 December 2020

Identifiers

PMCID

1865200

1 reference

10 August 2017

1 reference